AvenCell Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 22, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $112,000,000
Company Info
- Company Description
- AvenCell Therapeutics is focused on developing switchable CAR-T therapies aimed at treating acute myeloid leukemia and other blood cancers.
- Market
- Blood cancers